Notice Number: NOT-HD-16-015
Key Dates
Release Date: June 15, 2016
NOT-OD-13-030
PAR-16-106
Issued by
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Eye Institute (NEI)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institute on Dental and Craniofacial Research (NIDCR)
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs (ORIP)
Purpose
The purpose of this Notice is to clarify the NIH Policy on Post-Submission Application Materials for PAR-16-106 "Rapid Assessment of Zika Virus (ZIKV) Complications (R21)”.
NOT-OD-13-030 “Reminders and Updates: NIH Policy on Post-Submission Application Materials“ provides policy guidance for post-submission application materials. Post-submission application materials are those submitted after submission of the grant application but prior to the initial peer review. The NIH policy on post-submission application materials specifies that, for the majority of applications, the only post-submission materials that the NIH will accept are those resulting from unforeseen administrative issues. As described in NOT-OD-13-030, such materials must be received by the Scientific Review Officer one month (30 calendar days) prior to the peer review meeting, and demonstrate concurrence from the Authorized Organization Representative (AOR) of the applicant organization.
The Funding Opportunity Announcement (FOA) PAR-16-106 "Rapid Assessment of Zika Virus (ZIKV) Complications (R21)" is set up to accept applications on a continuous basis from March 20, 2016 until February 28, 2019 rather than specifying exact due dates. Therefore, the typical timelines for receipt, review, council, and award would not apply to applications submitted for this FOA. Specifically, R21 applications for PAR-16-106 will be handled on an expedited external peer review and award basis to meet the goals of this program. Because of this accelerated review schedule, the 30-day timeframe for submitting post-submission materials will not always be possible. Therefore, for applications submitted to PAR-16-106, post-submission materials must be received by the Scientific Review Officer (SRO) no later than 15 calendar days prior to the review meeting and must meet all the other requirements described in NOT-OD-13-030. Applicants are strongly encouraged to contact the respective Scientific Review Officer (SRO) before submitting any additional materials.
Inquiries
Please direct all inquiries to the Peer Review Contact(s) for PAR-16-106:
Sherry Dupere, PhD
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-451-3415
Email: [email protected]
Anne Schaffner, PhD
National Eye Institute (NEI)
Telephone: 301-451-2020
Email: [email protected]
Director, Office of Scientific Review
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0270
Email: [email protected]
Raymond Richard Schleef, PhD, MBA
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-669-5019
Email: [email protected]
David George, PhD
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Phone: 301-496-9474
Email: [email protected]
Yasaman Shirazi, PhD
National Institute of Dental and Craniofacial Research (NIDCR)
Telephone: 301-594-5593
Email: [email protected]
David Armstrong, PhD
National Institute of Mental Health (NIMH)
Telephone: 301-443-3534
Email: [email protected]
Ernest Lyons, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-9223
Email: [email protected]
and Human Services (HHS)
